Global Antifungal Drugs Market to Drive at a CAGR of 5% During the Forecast Period of 2022-2027 Cryptocurrency

Expert Market Reseach’s new report titled ‘Global Antifungal Drugs Market Report and Forecast 2022-2027’, gives an in-depth analysis of the global Antifungal Drugs market, assessing the market based on its segments such as Class of drugs, indication and major regions like Asia-Pacific, Europe, North America, Middle East and Africa and Latin America. The report tracks the latest industry trends and studies their impact on the overall market. It also assesses market dynamics, covering key demand and price indicators, as well as market analysis based on SWOT and Porter’s Five Forces models.

Get Free Sample Report With TOC:

Key highlights of the report include:

Market Overview (2017-2027)

  • Historical market size (2021): USD 13.86 billion
  • Forecast CAGR (2022-2027): 5%
  • Forecast market size (2027): 18.57 billion USD

The growth of the global antifungal drugs market is driven by the increasing prevalence of fungal diseases in the countries. The market is further aided by factors such as growing awareness of various fungal infections such as ringworm, candidiasis, and systemic mycosis, among others, rising number of antifungal drugs available over the counter (OTC) and l growing use of antifungal drugs in developing countries. In addition, increasing investments in research and development (R&D) activities and new drug pipelines by major pharmaceutical companies for the development of new and more effective antifungal drugs are expected to drive the market growth over the forecast period. .

Market segmentation

Antifungal drugs, also known as antifungal drugs, are pharmaceutical fungicides that help eliminate fungal infection from the body with minimal side effects.

Read Full Report with TOC:

Based on Drug Class, the market is segmented into:

  • Azoles
    • Voriconazole
    • Posaconazole
    • Isavuconazole (CRESEMBA)
    • Others
  • Echinocandins
    • Caspofungin
    • Micafungin (Mycamine/ Funguard)
    • Others
  • Polyenes
  • Amphotericin (AmBisome)
  • Others
  • Allylamines
  • Others

Based on the indication, the industry is divided into:

  • Dermatophytosis
  • Aspergillosis
  • candidiasis
    • Invasive candidiasis
    • Vulvovaginal candidiasis (VVC)
    • Candidiasis of the mouth/throat/esophagus
    • Others
  • Others

Regional antifungal drug markets include:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Market trends

Regionally, North America is expected to hold a major share of the global antifungal drugs market. This can be attributed to the growing awareness of hygiene, increasing prevalence of patients suffering from fungal infections, and increasing adoption of advanced therapies. Meanwhile, Europe is expected to follow North America due to growth in healthcare infrastructure, increased healthcare spending, etc. During the forecast period, Asia-Pacific is expected to grow at the fastest rate. This can be attributed to increased government spending in the healthcare sector and the growing number of pharmaceutical manufacturers in countries like India and China.

Latest News on Antifungal Drugs Market:

Main market players

Major players in the market are Abbott Laboratories, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc. and few others.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports and advisory services to our clients. We serve a wide clientele ranging from Fortune 1000 companies to small and medium-sized businesses. Our reports cover over 100 industries in established and emerging markets researched by our trained analysts who track the latest economic, demographic, business and market data globally.

At Expert Market Research, we tailor our approach based on the needs and preferences of our clients, providing them with valuable, actionable and up-to-date market insights, helping them realize their optimal growth potential. We offer market intelligence across a range of verticals including Pharmaceuticals, Food & Beverage, Technology, Retail, Chemicals & Materials, Energy & Mining, Packaging and agriculture.

Media Contact

Company name: EMR Inc.
Contact:-Ian Bell, Business Advisor
Email: [email protected]
Toll Free: USA +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States

Learn more about EMR Inc.’s Procurement Intelligence Services.

** At Expert Market Research, we always strive to give you the latest information. The figures in the article are only indicative and may differ from the actual report.

Comments are closed.